Editor: What To Know
- VGM is the largest and most comprehensive Member Service Organization (“MSO”) in the US for post-acute healthcare, which provides a range of support to its members including with the purchasing of medical equipment in the respiratory field.
- Belluscura, a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that it has entered into a Group Purchasing Organization Product Supply Agreement (the “Agreement”) for the supply of portable oxygen concentrators with VGM Group, Inc (“VGM”).
- VGM's providers will immediately gain access to Belluscura's award winning next generation portable oxygen concentrator, the X-PLOR®, which was launched in late June 2022, and later this year will gain access to Belluscura's transformational portable oxygen concentrator, the DISCOV-R™.
Belluscura, a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that it has entered into a Group Purchasing Organization Product Supply Agreement (the “Agreement”) for the supply of portable oxygen concentrators with VGM Group, Inc (“VGM”).
VGM is the largest and most comprehensive Member Service Organization (“MSO”) in the US for post-acute healthcare, which provides a range of support to its members including with the purchasing of medical equipment in the respiratory field.
Over 2,500 healthcare providers with nearly 7,000 locations across the US rely on VGM to connect them to valuable resources every single day.
VGM’s providers will immediately gain access to Belluscura’s award winning next generation portable oxygen concentrator, the X-PLOR®, which was launched in late June 2022, and later this year will gain access to Belluscura’s transformational portable oxygen concentrator, the DISCOV-R™.
The Agreement with VGM further expands Belluscura’s distribution network across the US and its routes to market.
Robert Rauker, CEO of Belluscura plc, said: “Our partnership with VGM enables us to work together to provide access to our next generation portable oxygen concentrators. The partnership provides a further opportunity to support the Group’s continued growth. We look forward to working with VGM in expanding access to our high performing, lighter oxygen technologies and improving the quality of life for patients.”
